PRGO News and Press, Perrigo Company plc From 08/08/19

Perrigo Company ( PRGO ) Q2 results : Revenues: $1,149M (-3.2%). More news on: Perrigo Company plc, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

Perrigo (NYSE: PRGO ): Q2 Non-GAAP EPS of $0.86 beats by $0.06 ; GAAP EPS of $0.07 misses by $0.15 . More news on: Perrigo Company plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

DUBLIN , Aug. 8, 2019 /PRNewswire/ -- GAAP ("reported") net sales were $1.15 billion , reflecting a 3% decline versus the prior year period. Non-GAAP ("adjusted") net sales increased by approximately 1% excluding the unfavorable impact of currency and exited businesses. Second qu...

ACIW , AMC , AMRC , AZUL , BAM , BPMP , CAH , CBB , CCOI , CEVA , CNNE , COMM , COT , CRON , CSWI , EBIX , ECOM , EGRX , EPAM , ESPR , FOCS , FOLD , GOGO , GTT , HIMX , HMHC , IBP , KDP , KHC , KOP , KTB , LAUR , LITE , LKSD , LNG , MGA , MMS , MPAA , ...

DUBLIN , Aug. 7, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products ™ " , today announced that Jeffrey C. Smith , Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP, w...

Drug distributors McKesson ( MCK -4.9% ), Cardinal Health ( CAH -5.4% ) and AmerisourceBergen ( ABC -4.7% ) are under pressure in apparent response to a Bloomberg repor t that they have proposed paying a total of $10B to settle all claims related their respective roles in the opioid e...

Two small-cap stocks on the radar today include SailPoint Technologies (NYSE:SAIL) and PetIQ (NASDAQ:PETQ). Let’s check out the potential here. Small-Cap Stocks to Watch: SailPoint At a current price of $20.93 USD, SailPoint Technologies could be an undervalued play. Af...

Background Pfizer ( PFE ) is spinning off its Upjohn unit and combining it with generic drugmaker Mylan ( MYL ) to create a giant off-patent group with global annual revenues worth about $20 billion. The all-stock deal will unite former branded blockbusters like Lipitor and Viagra with Myl...

The WSJ reports that Pfizer (NYSE: PFE ) is in talks with Mylan N.V. (NASDAQ: MYL ) to combine its off-patent drugs business with the latter. More news on: Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Limited, Healthcare stocks news, Merger & acquisition news, Stocks on th...

DUBLIN , July 25, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its second quarter calendar year 2019 financial results on Thursday, August 8, 2019 . The Company will host a conference call beginning at 8 a.m. (EDT) . The conf...